Patent ID: 9415030
Filing Date: 2016-08-16
CPC Classification: A61K

Claim Text:
1. A method for treating a subject having obsessive-compulsive disorder (OCD) or an obsessive-compulsive spectrum disorder (OCSD), the method comprising: administering to the subject (a) a therapeutic amount of a compound or a pharmaceutically acceptable salt thereof, wherein the compound comprises a glycine transporter inhibitor, and the therapeutic amount is effective to reduce symptoms of OCD or OCSD; (b) a therapeutic amount of arginine, wherein the therapeutic amount of arginine is effective to treat hyperammonemia without increasing inflammation; and (c) a therapeutic amount of a composition containing a selective serotonin reuptake inhibitor (SSRI), a neuroleptic, an anti-convulsant, an anti-depressant, an antiandrogen, or a combination thereof.